Consensus Recommendations for the Use of Anti-EGFR Therapies in Metastatic Colorectal Cancer
C. Cripps(Canadian Partnership Against Cancer), Ralph Wong(CancerCare Manitoba), Brian Colwell, Hagen F. Kennecke(Oregon Health & Science University), Sharlene Gill(Deventer Ziekenhuis), Benoît Samson(Hôpital Charles-Le Moyne), Scot Dowden, Michael P. Thirlwell(McGill University Health Centre), Jean A. Maroun(American Society of Clinical Oncology), Shahid Ahmed(Emory University)
Cited by 10
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k